Immediate Versus Interval Postpartum Use of the Levonorgestrel

Status Completed

Clinical Trial Summary

This study will evaluate if immediate postpartum placement of a levonorgestrel (LNG) contraceptive implant within 5 days of delivery improves implant utilization at 6 months postpartum compared to implant placement at 6-8 weeks postpartum among women in Uganda.

Clinical Trial Description

Waiting until 6 weeks postpartum to initiate contraception puts women at risk for unintended pregnancy and short birth intervals. Short birth intervals of less than 18 months are associated with an increased risk of preterm delivery and low birth weight infants.

Subdermal implants are advantageous for the postpartum period because they are long-acting, reversible, and highly effective, and they do not contain estrogen or require intrauterine placement. In observational studies postpartum continuation rates have been shown to be greater than 95% after 6 months and 86-87% after 1 year in US populations. Implants are not routinely available during the immediate postpartum period in Uganda, and availability could improve the contraceptive method mix for postpartum women in that country. The results of this study may support increasing access to a form of immediate postpartum LARC (long acting reversible contraception) in a developing country.

This is a randomized, controlled trial of the association between immediate postpartum contraceptive implant placement and implant utilization at 6 months postpartum among women in Uganda. This study will compare the proportion of women using the Levonorgestrel contraceptive implant at 6 months after delivery in women randomized to insertion within 5 days of delivery (immediate insertion) or 6 weeks after delivery (delayed insertion). The study population is women who have a delivery at Mulago hospital in Kampala, Uganda and choose a contraceptive implant for postpartum contraception.

The investigators plan to enroll 202 women who are planning to receive a postpartum Levonorgestrel contraceptive implant after delivery to find out whether the timing of postpartum administration of the implant (prior to hospital discharge or 6 weeks after delivery) affects implant utilization, satisfaction with the implant, vaginal bleeding or breastfeeding. ;

Study Design

Related Conditions & MeSH terms

Contraceptive Implant Utilization
Lactation

Clinical Trial Details

NCT number	NCT02341027
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	January 2015
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02542527` - Evaluation of the Functionality of a Fluid Filled Single Breast Pump	N/A
Terminated	`NCT02755194` - "Drugs in Lactation" Analysis Consortium
Terminated	`NCT00851591` - Effect of Fenugreek on Milk Production	N/A
Withdrawn	`NCT00181649` - Recombinant Human Prolactin for Lactation Induction	Phase 2
Completed	`NCT00181610` - Recombinant Human Prolactin for Lactation Induction	Phase 2
Completed	`NCT04024865` - Domperidone and Risk of Serious Cardiac Events in Postpartum Women
Terminated	`NCT02378233` - Iodine Status in Swedish Lactating Women - Effect of Iodine Supplementation in the Thyroid Function of Mother and Infant	N/A
Recruiting	`NCT06203444` - An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females	Phase 1
Completed	`NCT01747668` - Lactation Fortification Study	Phase 3
Completed	`NCT01463202` - Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression	Phase 4
Completed	`NCT02621827` - Vitamin D Half-life in Pregnancy and Lactation	N/A
Terminated	`NCT04146909` - The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women	N/A
Completed	`NCT04593719` - Effect of Lactation Management Model on Breastfeeding Process	N/A
Completed	`NCT01548313` - The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota
Completed	`NCT02690675` - Iron Supplement Effect on Child Development	N/A
Completed	`NCT05123183` - Nonpharmacological Methods and Lactation	N/A
Completed	`NCT03091985` - Influence of the Brownie Breast Shield on the Dynamics of Milk Removal	N/A
Completed	`NCT02190448` - Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation	N/A
Not yet recruiting	`NCT06264349` - Women and Maternity: Development of a Nutritional Education Project	N/A
Recruiting	`NCT02384655` - Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms